Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FE.1.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.64.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDP.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KR.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KZ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDSNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16939.3Singapore
GW.5.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JE.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.83NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.33.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.6.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCLNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used